Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Landscape of CDKN1B Mutations in Luminal Breast Cancer and Other Hormone-Driven Human Tumors.

Cusan M, Mungo G, De Marco Zompit M, Segatto I, Belletti B, Baldassarre G.

Front Endocrinol (Lausanne). 2018 Jul 17;9:393. doi: 10.3389/fendo.2018.00393. eCollection 2018. Review.

2.

Loss of p27kip1 increases genomic instability and induces radio-resistance in luminal breast cancer cells.

Berton S, Cusan M, Segatto I, Citron F, D'Andrea S, Benevol S, Avanzo M, Dall'Acqua A, Schiappacassi M, Bristow RG, Belletti B, Baldassarre G.

Sci Rep. 2017 Apr 4;7(1):595. doi: 10.1038/s41598-017-00734-3.

3.

p27kip1 expression limits H-Ras-driven transformation and tumorigenesis by both canonical and non-canonical mechanisms.

Pellizzari I, Fabris L, Berton S, Segatto I, Citron F, D'Andrea S, Cusan M, Benevol S, Perin T, Massarut S, Canzonieri V, Schiappacassi M, Belletti B, Baldassarre G.

Oncotarget. 2016 Oct 4;7(40):64560-64574. doi: 10.18632/oncotarget.11656.

4.

Preclinical validation of a novel compound targeting p70S6 kinase in breast cancer.

Segatto I, Massarut S, Boyle R, Baldassarre G, Walker D, Belletti B.

Aging (Albany NY). 2016 May;8(5):958-76. doi: 10.18632/aging.100954.

5.

Radiotherapy-induced miR-223 prevents relapse of breast cancer by targeting the EGF pathway.

Fabris L, Berton S, Citron F, D'Andrea S, Segatto I, Nicoloso MS, Massarut S, Armenia J, Zafarana G, Rossi S, Ivan C, Perin T, Vaidya JS, Avanzo M, Roncadin M, Schiappacassi M, Bristow RG, Calin G, Baldassarre G, Belletti B.

Oncogene. 2016 Sep 15;35(37):4914-26. doi: 10.1038/onc.2016.23. Epub 2016 Feb 15.

6.

p27kip1 controls H-Ras/MAPK activation and cell cycle entry via modulation of MT stability.

Fabris L, Berton S, Pellizzari I, Segatto I, D'Andrea S, Armenia J, Bomben R, Schiappacassi M, Gattei V, Philips MR, Vecchione A, Belletti B, Baldassarre G.

Proc Natl Acad Sci U S A. 2015 Nov 10;112(45):13916-21. doi: 10.1073/pnas.1508514112. Epub 2015 Oct 28.

7.

Time-tuning cancer therapy.

Baldassarre G, Segatto I, Belletti B.

Aging (Albany NY). 2015 Aug;7(8):531-2. No abstract available.

PMID:
26298846
Free PMC Article
8.

Genetic characterization of p27(kip1) and stathmin in controlling cell proliferation in vivo.

Berton S, Pellizzari I, Fabris L, D'Andrea S, Segatto I, Canzonieri V, Marconi D, Schiappacassi M, Benevol S, Gattei V, Colombatti A, Belletti B, Baldassarre G.

Cell Cycle. 2014;13(19):3100-11. doi: 10.4161/15384101.2014.949512.

9.

Surgery-induced wound response promotes stem-like and tumor-initiating features of breast cancer cells, via STAT3 signaling.

Segatto I, Berton S, Sonego M, Massarut S, Perin T, Piccoli E, Colombatti A, Vecchione A, Baldassarre G, Belletti B.

Oncotarget. 2014 Aug 15;5(15):6267-79.

10.

Contact inhibition modulates intracellular levels of miR-223 in a p27kip1-dependent manner.

Armenia J, Fabris L, Lovat F, Berton S, Segatto I, D'Andrea S, Ivan C, Cascione L, Calin GA, Croce CM, Colombatti A, Vecchione A, Belletti B, Baldassarre G.

Oncotarget. 2014 Mar 15;5(5):1185-97.

11.

p70S6 kinase mediates breast cancer cell survival in response to surgical wound fluid stimulation.

Segatto I, Berton S, Sonego M, Massarut S, Fabris L, Armenia J, Mileto M, Colombatti A, Vecchione A, Baldassarre G, Belletti B.

Mol Oncol. 2014 May;8(3):766-80. doi: 10.1016/j.molonc.2014.02.006. Epub 2014 Mar 12.

12.

Inhibition of breast cancer local relapse by targeting p70S6 kinase activity.

Segatto I, Berton S, Sonego M, Massarut S, D'Andrea S, Perin T, Fabris L, Armenia J, Rampioni G, Lovisa S, Schiappacassi M, Colombatti A, Bristow RG, Vecchione A, Baldassarre G, Belletti B.

J Mol Cell Biol. 2013 Dec;5(6):428-31. doi: 10.1093/jmcb/mjt027. Epub 2013 Jul 29. No abstract available.

PMID:
23899505
13.

Stathmin is dispensable for tumor onset in mice.

D'Andrea S, Berton S, Segatto I, Fabris L, Canzonieri V, Colombatti A, Vecchione A, Belletti B, Baldassarre G.

PLoS One. 2012;7(9):e45561. doi: 10.1371/journal.pone.0045561. Epub 2012 Sep 20.

Supplemental Content

Loading ...
Support Center